In Dsg2-mutant mice, anti-inflammatory treatment through inhibition of the NFκB signaling pathways was effective in reducing the structural and functional signs associated with AC disease progression (myocardial fibrosis, necrosis, inflammation, and arrhythmias; Chelko et al., 2019). The gene discussed is DSG2; the disease is Arrhythmia.